. . . . . . . . . . . . "[The combination treatment of cAT-MSC-IFN-I2 with cisplatin was more effective in inhibiting the growth of melanoma and resulted in significantly extended survival time than both an unengineered cAT-MSC-cisplatin combination group and a cisplatin-alone group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2015-02-21"^^ . . "Gene-disease associations manually curated."@en . "DisGeNET evidence - CURATED"@en . "2015-08-25T14:37:51+02:00"^^ . . . . . . . . . . . "v3.0.0.0" . "v3.0.0" .